Zhang J, Zhang J, Yang C
J Transl Med. 2025; 23(1):52.
PMID: 39806481
PMC: 11727735.
DOI: 10.1186/s12967-024-06063-0.
Kastendiek N, Coletti R, Gross T, Lopes M
BioData Min. 2024; 17(1):56.
PMID: 39696678
PMC: 11657291.
DOI: 10.1186/s13040-024-00411-y.
Grimi A, Bono B, Lazzarin S, Marcheselli S, Pessina F, Riva M
Int J Mol Sci. 2024; 25(16).
PMID: 39201639
PMC: 11354416.
DOI: 10.3390/ijms25168953.
Hwang Y, Lee D, Lee E, Oh J
Cells. 2024; 13(16.
PMID: 39195222
PMC: 11353125.
DOI: 10.3390/cells13161332.
Jamshidi-Mouselou M, Hashemi A, Jamshidi-Mouselou M, Farkhondeh T, Pourhanifeh M, Samarghandian S
Curr Med Chem. 2024; 31(26):4180-4198.
PMID: 38265392
DOI: 10.2174/0109298673266672231121173432.
The myocardium utilizes a platelet-derived growth factor receptor alpha (Pdgfra)-phosphoinositide 3-kinase (PI3K) signaling cascade to steer toward the midline during zebrafish heart tube formation.
Shrestha R, McCann T, Saravanan H, Lieberth J, Koirala P, Bloomekatz J
Elife. 2023; 12.
PMID: 37921445
PMC: 10651176.
DOI: 10.7554/eLife.85930.
Understanding Glioblastoma Signaling, Heterogeneity, Invasiveness, and Drug Delivery Barriers.
Rabah N, Ait Mohand F, Kravchenko-Balasha N
Int J Mol Sci. 2023; 24(18).
PMID: 37762559
PMC: 10532387.
DOI: 10.3390/ijms241814256.
New drug-like small molecule antagonizes phosphatidylinositol (3,4,5)-trisphosphate (PIP3) in patients with conotruncal heart defects.
Fayez A, Esmaiel N, Ashaat E, Refeat M, Lotfy R, Raouf H
J Taibah Univ Med Sci. 2023; 18(6):1244-1253.
PMID: 37250809
PMC: 10213100.
DOI: 10.1016/j.jtumed.2023.04.006.
A combination of metformin and epigallocatechin gallate potentiates glioma chemotherapy .
Kuduvalli S, Daisy P, Vaithy A, Purushothaman M, Muralidharan A, Agiesh K
Front Pharmacol. 2023; 14:1096614.
PMID: 37025487
PMC: 10070706.
DOI: 10.3389/fphar.2023.1096614.
Identification and validation of neurotrophic factor-related gene signatures in glioblastoma and Parkinson's disease.
Zhao S, Chi H, Yang Q, Chen S, Wu C, Lai G
Front Immunol. 2023; 14:1090040.
PMID: 36825022
PMC: 9941742.
DOI: 10.3389/fimmu.2023.1090040.
The myocardium utilizes Pdgfra-PI3K signaling to steer towards the midline during heart tube formation.
Shrestha R, McCann T, Saravanan H, Lieberth J, Koirala P, Bloomekatz J
bioRxiv. 2023; .
PMID: 36712046
PMC: 9881939.
DOI: 10.1101/2023.01.03.522612.
The Critical Role of RNA mA Methylation in Gliomas: Targeting the Hallmarks of Cancer.
Xu Z, Jiang J, Wang S
Cell Mol Neurobiol. 2022; 43(5):1697-1718.
PMID: 36104608
PMC: 11412196.
DOI: 10.1007/s10571-022-01283-8.
Ribonuclease A Family Member 2 Promotes the Malignant Progression of Glioma Through the PI3K/Akt Signaling Pathway.
Wu T, Chen Y, Yang L, Wang X, Chen K, Xu D
Front Oncol. 2022; 12:921083.
PMID: 35747836
PMC: 9211777.
DOI: 10.3389/fonc.2022.921083.
ZAP70 Activation Compensates for Loss of Class IA PI3K Isoforms Through Activation of the JAK-STAT3 Pathway.
Demir M, Cizmecioglu O
Cancer Diagn Progn. 2022; 2(3):391-404.
PMID: 35530641
PMC: 9066532.
DOI: 10.21873/cdp.10122.
Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma.
Behrooz A, Talaie Z, Jusheghani F, Los M, Klonisch T, Ghavami S
Int J Mol Sci. 2022; 23(3).
PMID: 35163279
PMC: 8836096.
DOI: 10.3390/ijms23031353.
TMEM60 Promotes the Proliferation and Migration and Inhibits the Apoptosis of Glioma through Modulating AKT Signaling.
Wu J, Tang X, Yu X, Zhang X, Yang W, Seth A
J Oncol. 2022; 2022:9913700.
PMID: 35027926
PMC: 8749377.
DOI: 10.1155/2022/9913700.
Neuronal-driven glioma growth requires Gαi1 and Gαi3.
Wang Y, Liu Y, Chen M, Cheng K, Qi L, Zhang Z
Theranostics. 2021; 11(17):8535-8549.
PMID: 34373757
PMC: 8343996.
DOI: 10.7150/thno.61452.
The lipid-lowering drug fenofibrate combined with si-HOTAIR can effectively inhibit the proliferation of gliomas.
Zhu W, Zhao H, Xu F, Huang B, Dai X, Sun J
BMC Cancer. 2021; 21(1):664.
PMID: 34082742
PMC: 8173837.
DOI: 10.1186/s12885-021-08417-z.
Involvement of PI3K Pathway in Glioma Cell Resistance to Temozolomide Treatment.
Zajac A, Sumorek-Wiadro J, Langner E, Wertel I, Maciejczyk A, Pawlikowska-Pawlega B
Int J Mol Sci. 2021; 22(10).
PMID: 34068110
PMC: 8152763.
DOI: 10.3390/ijms22105155.
Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme.
Tilak M, Holborn J, New L, Lalonde J, Jones N
Int J Mol Sci. 2021; 22(4).
PMID: 33673213
PMC: 7918566.
DOI: 10.3390/ijms22041831.